64 Trending Stocks

Fri, Nov 27, 2020

Vertex Pharmaceuticals

VRTX 226.71
8.61 (4.0%)

Open: 219.61 High: 226.72 Low: 219.61

9 x 226.71 = 2040.39
x $226.71 =

NASDAQ: VRTX $57 Billion Large-Cap. Nasdaq 100. S&P 500. Health Care Sector. Biotech & Pharma Industry. 5 Year Return 75%. 1 Year Return 2%. 2020 YTD Return 3%. Since Earnings 19%.

ST

External Links

Free Channels & more...

For Starters

Charts

image
image

52WL $199.16

The 52 Week Low is $199.16 set on Mon, Mar 16, 2020.

52WH $304.00

The 52 Week High is $304.00 set on Mon, Jul 20, 2020.

ATH $304.00

The All-Time High is $304.00 set on Mon, Jul 20, 2020.

52 Week Range

$199.16
$304.00
Mar 16, 2020
Jul 20, 2020

Earnings

2.56

Earnings Per Share

20.79

Price To Earnings Ratio


Q1 Earnings for Jan, Feb & Mar

Wed, Apr 29, 2020

Since Q1 Earnings Report

VRTX 11.8%


Q2 Earnings for Apr, May & Jun

Thu, Jul 30, 2020

Since Q2 Earnings Report

VRTX 18.7%

Dividends

0.00

Dividend Yield

0.00

Dividend Rate

--

Ex-Dividend Date

--

Dividend Payment Date

--

Dividend Frequency

0

Dividend History

Profile

Vertex Pharmaceuticals trades on the NASDAQ. VRTX's market cap is 56.7 Billion.

Vertex Pharmaceuticals discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, Symdeko, and Trikafta for cystic fibrosis, where Vertex therapies remain the standard of care globally. Vertex's pipeline also includes therapies for cancer, pain, inflammatory diseases, influenza, and other rare diseases.

Website

Related Channels

Account Channels

Track your portfolio and more.